Biohaven Pharmaceutical Holding Co Ltd.
SEC CIK 1689813 · BHVN · last insider filing 2022-10-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Childs John W | Director | filed 2017 - 2022 |
| Gregory Julia P | Director | filed 2017 - 2022 |
| Hugin Robert J | Director | filed 2020 - 2022 |
| Bailey Gregory | Director | filed 2017 - 2022 |
| Heffernan Michael Thomas | Director | filed 2020 - 2022 |
| Coric Vlad | Director · Chief Executive Officer | filed 2017 - 2022 |
| Mehta Kishan | Director | filed 2021 - 2022 |
| Antonijevic Irina | Director | filed 2022 - 2022 |
| Doogan Declan | Director | filed 2017 - 2022 |
| Aguiar Eric | Director | filed 2017 - 2020 |
| Repella Robert | Director | filed 2018 - 2019 |
| Cha Albert | Director | filed 2017 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jones William A JR | CCO-Migraine & Common Disease | filed 2019 - 2022 |
| Gentile Kimberly | VP of Operations | filed 2017 - 2022 |
| Tilton John | Chief Commercial Officer | filed 2017 - 2022 |
| Engelhart James | Strategic Advisor | filed 2017 - 2022 |
| Conway Charles | Chief Scientific Officer | filed 2017 - 2022 |
| Stock Elyse | Chief Medical Officer | filed 2019 - 2022 |
| Clark George C. | VP, Chief Accounting Officer | filed 2021 - 2022 |
| Buten Matthew | Officer | filed 2021 - 2022 |
| Berman Robert | Special Projects & Med Ovrsght | filed 2017 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.